Wilate

Wilate is a human-derived coagulation factor VIII and von Willebrand factor concentrate used to manage bleeding disorders. This intravenous therapy supports hemostasis in conditions like hemophilia A and von Willebrand disease. Ideal for patients requiring reliable clotting support.

Wilate is used to treat and prevent bleeding episodes in patients with hemophilia A or von Willebrand disease. It helps restore normal clotting function by providing essential clotting factors. This medication is administered intravenously under medical supervision. Commonly prescribed for routine prophylaxis or on-demand treatment.

Wilate works by replenishing missing or deficient clotting factors in the bloodstream. Patients may experience improved clotting ability following administration. Effects vary based on individual conditions and dosing. Regular use may help reduce the frequency of bleeding episodes.

Store Wilate in a refrigerator at 2–8°C (36–46°F) and protect from light. Do not freeze or shake the vial. Use only if the solution is clear and free of particles. Discard any unused portion after administration. Always follow healthcare provider instructions for safe handling and disposal.

Wilate may interact with other medications affecting blood clotting, such as anticoagulants or antiplatelet drugs. Avoid alcohol and herbal supplements that may increase bleeding risk. Consult a healthcare provider before combining with other therapies. No known severe drug-drug interactions have been reported.